Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Journal of Clinical Medicine
|
June 10, 2022
Pathophysiology and Clinical Management of Bile Acid Diarrhea
Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Neurogastroenterology and Motility
|
March 7, 2019
Nerve fiber overgrowth in patients with symptomatic diverticular disease
Maria Raffaella Barbaro, Cesare Cremon, Daniele Fuschi, et al.
Journal of Clinical Gastroenterology
|
September 8, 2012
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome
Giovanni Barbara, Lisa Zecchi, Raffaella Barbaro, et al.
Neurogastroenterology and Motility
|
May 9, 2025
Therapeutic Role of Probiotics for the Treatment of Dyspepsia: A Review of the Literature
Giovanni Marasco, Miriam Fiocca, Cesare Cremon, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 9, 2016
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism
Maria Raffaella Barbaro, Antonio Di Sabatino, Cesare Cremon, et al.
Pain
|
March 20, 2018
Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons
Cleo Desormeaux, Tereza Bautzova, Sonia Garcia-Caraballo, et al.
Gut Microbes
|
November 1, 2023
Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis
Giorgio Gargari, Giacomo Mantegazza, Valentina Taverniti, et al.
Neurogastroenterology and Motility
|
July 24, 2019
µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients
Giovanni Dothel, Lin Chang, Wendy Shih, et al.
The American Journal of Gastroenterology
|
March 20, 2026
Antibiotic use during gastrointestinal infections increases the risk of developing irritable bowel syndrome: a Systematic Review and Meta-Analysis
Luigi Colecchia, Giovanni Marasco, Cecilia Capelli, et al.
International Journal of Molecular Sciences
|
October 28, 2023
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases
Giovanni Marasco, Pierfrancesco Visaggi, Mariagiulia Vassallo, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Journal of Clinical Medicine
|
June 10, 2022
Pathophysiology and Clinical Management of Bile Acid Diarrhea
Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, et al.
Neurogastroenterology and Motility
|
March 7, 2019
Nerve fiber overgrowth in patients with symptomatic diverticular disease
Maria Raffaella Barbaro, Cesare Cremon, Daniele Fuschi, et al.
Journal of Clinical Gastroenterology
|
September 8, 2012
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome
Giovanni Barbara, Lisa Zecchi, Raffaella Barbaro, et al.
Neurogastroenterology and Motility
|
May 9, 2025
Therapeutic Role of Probiotics for the Treatment of Dyspepsia: A Review of the Literature
Giovanni Marasco, Miriam Fiocca, Cesare Cremon, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 9, 2016
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism
Maria Raffaella Barbaro, Antonio Di Sabatino, Cesare Cremon, et al.
Pain
|
March 20, 2018
Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons
Cleo Desormeaux, Tereza Bautzova, Sonia Garcia-Caraballo, et al.
Gut Microbes
|
November 1, 2023
Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis
Giorgio Gargari, Giacomo Mantegazza, Valentina Taverniti, et al.
Neurogastroenterology and Motility
|
July 24, 2019
µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients
Giovanni Dothel, Lin Chang, Wendy Shih, et al.
The American Journal of Gastroenterology
|
March 20, 2026
Antibiotic use during gastrointestinal infections increases the risk of developing irritable bowel syndrome: a Systematic Review and Meta-Analysis
Luigi Colecchia, Giovanni Marasco, Cecilia Capelli, et al.
International Journal of Molecular Sciences
|
October 28, 2023
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases
Giovanni Marasco, Pierfrancesco Visaggi, Mariagiulia Vassallo, et al.
Page
of 6